Alomfilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alomfilimab, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]